Lisocabtagene maraleucel, sold under the brand name Breyanzi, is a cell-based gene therapy used to treat B-cell lymphomas, including follicular lymphoma. From Wikipedia
The pharmaceutical giant's strong performance is driven by robust sales of Eliquis and new growth drugs.
